IOLCP · IOL Chemicals and Pharmaceuticals Limited · Financials
Volume · Nov 13
157.59K
Avg daily vol (3M)
274.4K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
23.19B
+11.5%
FY2026
Net Income
1.38B
+36.2%
FY2026
Operating Cash Flow
2.14B
+20%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|---|
| INR | 27.51B | 23.19B | 20.79B | 21.33B | 22.17B | 21.84B |
| INR | 840.1M | 802.3M | 719.9M | 629.1M | 461.6M | 432.6M |
| INR | 159.2M | 145.5M | 147.6M | 161M | 164.7M | 82.9M |
| INR | 2.72B | 1.84B | 1.38B | 1.82B | 1.89B | 2.25B |
| INR | 691.3M | 467.2M | 368.9M | 472.2M | 495.1M | 571.8M |
| INR | 2.03B | 1.38B | 1.01B | 1.34B | 1.39B | 1.68B |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 1.41B in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.